Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Phase III Study of Ficlatuzumab in Combination with Cetuximab in Participants with Recurrent or Metastatic R/M HPV-Negative Head and Neck Squamous Cell Carcinoma FIERCE-HN
Study Type: Treatment
Phase: III
NCTID: NCT06064877
Principal Investigator:
Prakash Neupane
A Randomized, Masked, Placebo Controlled, Phase II Trial of Concurrent Chemoradiation with BMX-001 in Patients with Head and Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
Study Type: Supportive Care
Phase: II
NCTID: NCT06532279
Principal Investigator:
Chris Lominska
A Phase 2 Study Using Chemoimmunotherapy with Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma NPC
Study Type: Treatment
Phase: II
NCTID: NCT06064097
Principal Investigator:
Keith August
A Phase II Trial of HER2-Targeted Therapies for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Study Type: Treatment
Phase: II
NCTID: NCT05408845
Principal Investigator:
Prakash Neupane
Phase I/Ib Study of AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Cancer
Study Type: Treatment
Phase: I
NCTID: NCT05172245
Principal Investigator:
Chris Lominska
A Multicenter, Randomized, Double-Blind, Phase II/III Study of BCA101 or Placebo in Combination with Pembrolizumab for First Line Treatment of PD-L1-positive, Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Study Type: Treatment
Phase: II/III
NCTID: NCT06788990
Principal Investigator:
Prakash Neupane
Implementing the NYU Electronic Patient Visit Assessment ePVA for Head and Neck Cancer In Rural and Urban Populations
Study Type: Supportive Care
Phase: N/A
NCTID: NCT06030011
Principal Investigator:
Chris Lominska
COMETH Study: Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head Neck Oncology
Study Type: Other
Phase: N/A
NCTID: NCT07550049
Principal Investigator:
Chao Huang
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Study Type: Treatment
Phase: II/III
NCTID: NCT04333537
Principal Investigator:
Andres Bur
TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Head Neck Squamous Cell Carcinoma HNSCC
Study Type: Other
Phase: N/A
NCTID: NCT06163534
Principal Investigator:
Prakash Neupane